Integration of molecular features with clinical information for predicting outcomes for neuroblastoma patients
Abstract Background Neuroblastoma is one of the most common types of pediatric cancer. In current neuroblastoma prognosis, patients can be stratified into high- and low-risk groups. Generally, more than 90% of the patients in the low-risk group will survive, while less than 50% for those with the hi...
Main Authors: | , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2019-08-01
|
Series: | Biology Direct |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s13062-019-0244-y |